This result can be due to two different factors: (i) NPM1-AML mutations are always heterozygous, hampering the total absence of nucleolar NPM1, and (ii) the concomitant DNMT3A R882C mutation, which can further affect nuclear pathways and composition61. This evidence concerns the gene DNMT3A and acute myeloid leukemia.